The Antibacterial and Anti-biofilm Activities of Two Thiazolidione Derivatives (H2-60 and H2-81) Against Clinical Enterococcus Faecium Strains

Zhong Chen,Yanpeng Xiong,Yuanyuan Tang,Yuxi Zhao,Junwen Chen,Jinxin Zheng,Yang Wu,Qiwen Deng,Di Qu,Zhijian Yu

DOI: https://doi.org/10.21203/rs.3.rs-635478/v1

2021-01-01

Abstract:Abstract Background: Previous reports have demonstrated two thiazolidione derivatives (H2-60 and H2-81) can robustly inhibit the planktonic growth and biofilm formation of S. epidermidis and S. aureus by targeting the histidine kinase (HK) YycG. Whereas the antibacterial and anti-biofilm activity of these two thiazolidione derivatives (H2-60 and H2-81) against Enterococcus faecium remains elusive. Here, the YycG recombinant proteins containing HisKA and HATPase_c domain of E. faecium DO were in vitro expressed in E. coli competent cell BL21 (DE3) and then purified for the autophosphorylation test, indicating these two thiazolidione derivatives (H2-60 and H2-81) could directly impact the kinase phosphoration activity of YycG of E. faecium.Results: The MICs of H2-60 and H2-81 in the clinical isolates of E. faecium was in the range from 3.125mg/L to 25mg/L. Moreover, either H2-60 or H2-81showed the excellent bactericidal activity against E. faecium with the single dose or its combination with daptomycin (4 × MIC) by time-killing assay. Furthermore, over 90% of E. faecium biofilm formation could markedly be inhibited by two thiazolidione derivatives (H2-60 and H2-81) within 1/4×MIC value. In addition, the frequency of the eradicated viable cells embedded in mature biofilm were evaluated by the confocal laser microscopy, suggesting that of H2-60 combined with ampicillin or daptomycin was significantly high when compared with its monotherapy (78.17% and 74.48%vs.41.59%, respectively, P< 0.01). Conclusion: Two thiazolidione derivatives (H2-60 and H2-81) exhibit the robust antibacterial and anti-biofilm activity against E. faecium by targeting the histidine kinase (HK) YycG.